Here are relevant reports on : natural-refrigerants-research
-
Natural Dyes Market by Type (Plant Based, Animal Based, Mineral Based), Structure, Form, Application, End-Use Industry (FnB, Cosmetic & Personal Care, Pharmaceuticals, Pulp & Paper, Packaging, Stationary & Art Supplies) - Global Forecast to 2029
The natural dyes market is expected to grow from USD 4.8 Billion in 2024 to USD 6.4 Billion by 2029, at a CAGR of 5.7% during the forecast period. Acquisitions, new product launches, expansion and partnerships are the major growth strategies adopted by the key players in the market. The key global players in the natural dyes market include Abbey Color (US), AMA Herbal (India), Pylam Products Company Inc. (US), Archroma (Switzerland), GNT Group (Netherlands), Stony Creek Colors (US), NIG GmbH (Germany), Givaudan (Switzerland), Dohler GmbH (Germany), and Couleurs DE Plantes (France)
- Published: September 2024
- Price: $ 4950
- TOC Available:
-
Immunoprecipitation Market by Product (Kit, Reagent (Antibodies, Magnetic Buffer)), Type (Individual IP, Coimmunoprecipitation, CHIP), End User (Academics, Research Institutes, Pharmaceutical and Biotechnology Companies) & Region - Global Forecast to 2024
The immunoprecipitation market is projected to reach USD 750 million by 2024, at a CAGR of 5.0%. The growth of this market is majorly driven by the increasing research in the life sciences industry and the growing need to identify antigens associated with autoimmune diseases (through antigen-antibody interaction to understand disease mechanisms and develop relevant drugs targeting these diseases). The prominent players in the global immunoprecipitation market are Thermo Fisher Scientific (US), Abcam (UK), and Merck KGaA (Germany)
- Published: February 2019
- Price: $ 4950
- TOC Available:
-
Cell Signaling Market by Type (Endocrine, Paracrine), Pathway (Akt, AMPK, Hedgehog, Notch), Product (Consumables, Instruments), Technology (Flow Cytometry, ELISA, Mass Spectrometry) & Application (Research, Cancer, Immunology) - Global Forecast to 2022
The cell signaling market is projected to reach USD 3.51 Billion by 2022 from USD 2.53 Billion in 2017, at a CAGR of 6.8%. The term “cell signaling” is used to define the complex interactive system of signals that regulates and mediate various cellular responses in the human body.
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
Quantum Computing in Automotive Market by Application (Route Planning & Traffic Management, Battery Optimization, Material Research, Production Planning & Scheduling), Deployment, Component, Stakeholder & Region - Global Forecast to 2035
The automotive quantum computing market is projected to reach USD 5,203 million by 2035, at a CAGR of 49.0% during the forecast period. The quantum computing in automotive market is dominated by giants such as IBM Corporation (US), Microsoft Corporation (US), D-wave systems Inc. (US), Amzon (US), Rigetti & Co, LLC (US), Alphabet Inc. (US), Accenture Plc (Ireland), Terra Quantum (Switzerland), and PASQAL (France). These companies adopted several strategies to gain traction in the quantum computing in automotive market. New product development, partnerships, and expansion strategies from 2018 to 2022 helped them to innovate its offerings and broaden its customer base.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Docking), Solution (Software, Services), Application (Drug Development), End User (Pharmaceutical, Biotechnology, Contract Research Organizations) & Region - Global Forecast to 2025
The global drug discovery informatics market growth is primed to transition from $2.2 billion in 2020 to $3.5 billion by 2025, showcasing a strong CAGR of 9.3%. The market is primarily driven by increased R&D spending, especially in rare diseases, and the growing adoption of informatics in drug discovery.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
Brain Computer Interface Market by Product (Non-invasive, Invasive, Partial invasive), Technology (EEG, MEG, ECoG, fMRI), Application (Disability/Rehabilitation, Assistive technologies, Mental health, Research), End User - Global Forecast to 2029
The global brain computer interface market, valued at US$235 million in 2023, stood at US$262 million in 2024 and is projected to advance at a resilient CAGR of 14.1% from 2024 to 2029, culminating in a forecasted valuation of US$506 million by the end of the period. The growth of this market is driven by the growing incidence & prevalence of neurological disorders, increasing demand for non-invasive and wearable brain computer interface devices, and rising Investments in research and development.
- Published: May 2024
- Price: $ 4950
- TOC Available:
-
Nanotechnology in Medical Devices Market by Product (Biochip, Implant Materials, Medical Textiles, Wound Dressing, Cardiac Rhythm Management Devices, Hearing Aid), Application (Therapeutic, Diagnostic, Research) - Global Forecast to 2019
The global nanotechnology-based medical devices market is expected to grow at a significant CAGR of around 11-12% during the forecast period (2014–2019). The market is mainly driven by the growth in aging population, rising adoption of nanotechnology-based medical devices, and increased nanotechnology R&D expenditure. In addition, the governments of several nations are investing heavily in developing and commercializing new nanotechnology products. However, safety issues regarding nanotechnology-based medical devices, stringent regulatory guidelines, and time-consuming approval processes for these devices are hampering the growth of this market to a certain extent. The global nanotechnology-based medical devices market was valued at around $5 billion in 2014 and is poised to grow at a CAGR of around 11-12% during the forecast period (2014 to 2019).
- Published: March 2015
- Price: $ 4950
- TOC Available:
-
Flow Cytometry Market by Technology (Cell-based, Bead-Based), Product & Service (Analyzer, Sorter, Consumables (Antibodies, Assays, Kits), Software), Application (Research (Stem Cell), Clinical (Cancer)), End User (Hospital) - Global Forecast to 2033
The global flow cytometry market, valued at US$4.87 billion in 2024, stood at US$5.06 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2025 to 2033, culminating in a forecasted valuation of US$9.85 billion by the end of the period. The major factors driving the growth in the flow cytometry market include advancements in technology, increasing adoption of flow cytometry products in clinical diagnostics, rising prevalence of chronic diseases, growing biopharmaceutical R&D, and the need for precision medicine.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Medical Refrigerators Market by Type, End Use (Blood Banks, Pharmaceutical Companies, Hospital & Pharmacies, Research Institutes, Medical Laboratories, Diagnostic Centre), & Region(North America, Europe, APAC, MEA, South America) - Global Forecast to 2026
The medical refrigerators market is expected to grow from USD 3.5 Billion in 2020 to USD 4.9 Billion by 2026, at a compound annual growth rate (CAGR) of 6.0% during the forecast period.The key market players Thermo Fisher Scientific Inc. (US), Blue Star Limited (India), Haier Biomedical (China), Aucma (China), Standex International Corporation (US), Godrej & Boyce Manufacturing Co Ltd. (India), Helmer Scientific Inc. (US), Vestfrost Solutions (Denmark), Zhongke Meiling Cryogenics Company Limited (China), Fiochetti (Italy), PHC Holdings Corporation (Japan), Follett LLC (US), Labcold (UK), Dulas Ltd. (UK), HMG India (India)
- Published: February 2022
- Price: $ 4950
- TOC Available:
-
Specialty PACS Market by Type (Radiology, Orthopedics, Oncology, Pathology, Endoscopy, Women's Health), Deployment Model (On premise, Cloud), Component (Software, Service), End User (Hospital, Clinic, Diagnostic Centers, Research) - Global Forecasts to 2024
The global specialty PACS market size is projected to reach USD 3.5 billion in 2024, at a CAGR of 6.0%. Some of the prominent players offering in this market includes IBM Corporation (Merge Healthcare Incorporated) (US), McKesson Corporation (US), Agfa Healthcare (Belgium), Carestream Health (a part of Onex Corporation) (Canada), Philips Healthcare (Netherlands), Sectra AB (Sweden), Siemens Healthineers (Germany), Novarad (US), INFINITT North America (US), Intelerad Medical Systems (Canada), Topcon Corporation (Japan), Sonomed Escalon (US), Canon USA, Inc. (US) (a subsidiary of Canon Inc.), Visbion (UK), and EyePACS, LLC (US).
- Published: September 2019
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
